Market Overview:
Escitalopram oxalate is a drug used to treat depression, obsessive-compulsive disorder, anxiety, and other conditions. It belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). Escitalopram oxalate is available as an oral liquid, tablet, and other form. The global escitalopram oxalate market was valued at $XX million in 2017 and is projected to reach $XX million by 2030 at a CAGR of XX%. Some of the factors that are driving the growth of the global escitalopram oxalate market are increasing prevalence of mental disorders, rising geriatric population susceptible to mental disorders, growing demand for better treatment options for mental disorders. However, some factors such as high cost associated with treatment and side effects associated with SSRI therapy are restraining the growth of this market.
Product Definition:
Escitalopram oxalate is a selective serotonin reuptake inhibitor (SSRI) antidepressant drug. It is prescribed for the treatment of major depressive disorder, generalized anxiety disorder, and obsessive-compulsive disorder. Escitalopram oxalate has been found to be more effective than other SSRIs in treating depression.
Oral Liquid:
Oral liquid is a form of drug delivery system that allows the formulation to be administered in doses smaller than those that can be administered through the mouth. The oral liquid dosage forms are available in two types, namely non-prescription and prescription. Non-prescription oral liquids have their usage limited to specific medical conditions whereas prescription oral liquids have a wider scope of application owing to regulatory authorization for its use in treating certain diseases and disorders.
Tablet:
Escitalopram oxalate is used for the treatment of depression and anxiety disorders. It is also used to treat panic disorder, agoraphobia, social anxiety disorder and chronic pain. Escitalopram oxalate may also be prescribed for other conditions; however, these are less prevalent conditions that require further research.
Application Insights:
Major applications of escitalopram oxalate include treat depression, treat obsessive-compulsive disorder, and treat anxiety. The others application segment includes the treatment of eating disorders such as anorexia and bulimia. In addition to this, it is also used in the treatment of panic disorder along with other mental illnesses such as PTSD and MDD (major depressive disorder).
The global market for depression was valued at USD 846.9 million in 2017 owing to increasing awareness about various treatments including medication for depression coupled with rising incidences globally. According to WHO, approximately 1 billion people suffer from clinical depression every year which is expected to increase over the coming years due to factors such as changing lifestyles and growing pressure on individuals by family & friends or society in general leading them towards a negative mindset resulting in Depression.
Regional Analysis:
Europe was the largest market for global esitalopram oxalate in 2016, followed by North America. The presence of key players and availability of branded drugs are some factors responsible for their large share. In addition, high awareness levels about depression and anxiety disorders among the population is also expected to drive growth over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions owing to a large patient pool with unmet medical needs coupled with rising disposable income in emerging countries such as China & India and Indonesia & Malaysia. Moreover, increasing government initiatives such as “One Belt One Road†(OBOR) project between China and Central Asia along with other developing nations are expected to open new markets over next few years which will further boost growth during forecast period (2018 - 2030).
Growth Factors:
- Escitalopram Oxalate is a highly effective antidepressant that has been proven to be safe and well tolerated.
- Escitalopram Oxalate is the most prescribed antidepressant in the world.
- The long-term safety and efficacy of Escitalopram Oxalate has been demonstrated in numerous clinical trials.
- Escitalopram Oxalate is available in a variety of formulations, making it easy to find a dosage that works for you.
- Escitalopram Oxalate can be taken with or without food, making it convenient for people on the go
Scope Of The Report
Report Attributes
Report Details
Report Title
Escitalopram Oxalate Market Research Report
By Type
Oral Liquid, Tablet, Other
By Application
Treat Depression, Treat Obsessive-Compulsive Disorder, Treat Anxiety, Others
By Companies
Xian.-Janssen, JEWIM PHARMA, Ke Lun, Dr Reddy's, HUAHAI PHARMACEUTICAL, Nishchem International Pvt
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
130
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Escitalopram Oxalate Market Report Segments:
The global Escitalopram Oxalate market is segmented on the basis of:
Types
Oral Liquid, Tablet, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Treat Depression, Treat Obsessive-Compulsive Disorder, Treat Anxiety, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Xian.-Janssen
- JEWIM PHARMA
- Ke Lun
- Dr Reddy's
- HUAHAI PHARMACEUTICAL
- Nishchem International Pvt
Highlights of The Escitalopram Oxalate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Liquid
- Tablet
- Other
- By Application:
- Treat Depression
- Treat Obsessive-Compulsive Disorder
- Treat Anxiety
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Escitalopram Oxalate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Escitalopram oxalate is an antidepressant medication that is used to treat major depressive disorder (MDD). It works by increasing the levels of serotonin in the brain.
Some of the major players in the escitalopram oxalate market are Xian.-Janssen, JEWIM PHARMA, Ke Lun, Dr Reddy's, HUAHAI PHARMACEUTICAL, Nishchem International Pvt.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Escitalopram Oxalate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Escitalopram Oxalate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Escitalopram Oxalate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Escitalopram Oxalate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Escitalopram Oxalate Market Size & Forecast, 2020-2028
4.5.1 Escitalopram Oxalate Market Size and Y-o-Y Growth
4.5.2 Escitalopram Oxalate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral Liquid
5.2.2 Tablet
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Treat Depression
6.2.2 Treat Obsessive-Compulsive Disorder
6.2.3 Treat Anxiety
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Escitalopram Oxalate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Escitalopram Oxalate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral Liquid
9.6.2 Tablet
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Treat Depression
9.10.2 Treat Obsessive-Compulsive Disorder
9.10.3 Treat Anxiety
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral Liquid
10.6.2 Tablet
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Treat Depression
10.10.2 Treat Obsessive-Compulsive Disorder
10.10.3 Treat Anxiety
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral Liquid
11.6.2 Tablet
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Treat Depression
11.10.2 Treat Obsessive-Compulsive Disorder
11.10.3 Treat Anxiety
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral Liquid
12.6.2 Tablet
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Treat Depression
12.10.2 Treat Obsessive-Compulsive Disorder
12.10.3 Treat Anxiety
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral Liquid
13.6.2 Tablet
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Treat Depression
13.10.2 Treat Obsessive-Compulsive Disorder
13.10.3 Treat Anxiety
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Escitalopram Oxalate Market: Competitive Dashboard
14.2 Global Escitalopram Oxalate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Xian.-Janssen
14.3.2 JEWIM PHARMA
14.3.3 Ke Lun
14.3.4 Dr Reddy's
14.3.5 HUAHAI PHARMACEUTICAL
14.3.6 Nishchem International Pvt
